TD TRICYCLIC ANTIDEPRESSANTS— 510(k) K853113

Name: FDA 510(k) clearance K853113
Creator: U.S. Food and Drug Administration
Published: 1985-08-12

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K853113 for TD TRICYCLIC ANTIDEPRESSANTS, Substantially Equivalent on 1985-08-12. Applicant: Abbott Laboratories. Device class: 2.

Clearance details

Applicant: Abbott Laboratories
Product code: Code LFG
Device class: Class 2
Regulation: 21 CFR 862.3910
Advisory panel: Clinical Toxicology
Date received: 1985-07-24
Decision date: 1985-08-12
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Abbott Park, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LFG

view all

K151348 — Healgen Propoxyphene Test (Strip, Cassette, Cup, Dip Card), Healgen Nortriptyline Test (Strip, Cassette, Cup, Dip Card), Healgen EDDP (Methadone Metabolite) Test (Strip, Cassette, Cup, Dip Card)2015-08-18
K142609 — CR3 Keyless Split Sample Cup Nortriptyline-Buprenorphine2014-12-18
K112395 — WONDFO PHENCYCLIDINE URINE TEST, TRICYCLIC ANTIDEPRESSANTS URINE TEST2011-09-09
K072062 — UCP MULTIPLE DRUG SCREEN TEST CUPS2007-09-20
K061457 — UCP RAPID DRUG SCREENING TRICYCLIC ANTIDEPRESSANT, PROPOXYPHENE TESTS2006-08-21

More clearances from Abbott Laboratories

view all

K252424 — Anti-HCV Next2026-04-28
K243500 — ARCHITECT iGentamicin2025-07-09
K243168 — Alinity i Rubella IgG2025-06-20
K243283 — Alinity h-series System2025-02-20
K233932 — Alinity i Toxo IgM2024-08-30

Data sourced from openFDA. This site is unofficial and independent of the FDA.